The student evaluations of the course instructors and material were overwhelmingly positive, with >90% of the responding students reporting overall satisfaction with the course experience. One student’s feedback: “I didn’t know exactly what to expect when I registered for the course. I was very pleasantly surprised that all the information that was presented was highly relevant for the work I do and provided some of the initial tools and framework to understand the concepts related to them.”
The micro-certificate development and delivery was led by Dr. Dean Regier, who is also the Chair of the ATM Regulatory Advisory Council. Dr. Regier is an associate professor at the School of Population and Public Health, a Senior Scientist within Cancer Control Research and the Director of the Health Economics Support and Research Unit (HESRU) at BC Cancer.
Dr. Regier says: “Regulatory Science is the future of translational medicine. Our faculty presented the cutting-edge methods and thinking necessary to get sustainable and effective innovation to patients sooner.”Dr. Regier adds “We were once again extremely excited about the level of engagement from the learners and their ability and eagerness to engage and apply with the course material. Our experience continues to underscores the enthusiasm for translational medicine and regulatory science from all stakeholders involved in our life sciences ecosystems”.
With financial support from the BC Ministry of Advanced Education and Skills Training, the ATM partnered with UBC Extended Learning to offer the UBC Micro-certificate in Regulatory Affairs for the Life Sciences. The program consisted of two five-week part-time courses, which ran back-to-back September to November 2022, that could be taken separately or stacked into a UBC micro-certificate.
The UBC micro-certificate will be offered annually as part of a larger regulatory science program being built at UBC.
The importance of regulatory affairs is also currently of interest to the Government of Canada, whose Medical Devices Compliance Program (MDCP) has launched a new interactive e-learning course to ensure Canadians are provided health products that are safe. The course is free, open to everyone, and aims to provide “explanations of post-market regulatory requirements for medical devices in Canada” and “the information necessary for stakeholders to fulfill their regulatory responsibilities”. Access instructions to activate the course here.
The Faculty of Medicine is excited to announce that the Multidisciplinary Research Program in Medicine (FoM MRPM) is relaunching for Summer 2023. The aim of this program is to facilitate and fund interdisciplinary and multidisciplinary research at UBC. Project applications require two faculty supervisors: one from the FoM and the other a non-FoM UBC faculty member.
The deadline to apply for project funding is January 19th 2023, and student applications will open in February.
Applications should be submitted in research pairs and supervisors should search for a partner capable of providing specific research expertise. Finding a research partner is the responsibility of the supervisor. Students and supervisors apply separately. Supervisors will be provided a list of eligible students following project approval. Supervisors will receive up to three students, two non-MD undergraduate students (in their second year or higher) for 16-weeks ($8,400 student stipend) and one optional first-year MD student for 8-weeks ($3,200 student stipend). Supervisors are required to pay at least $2,400 per non-MD student contingent on eligible student awards.
The UBC School of Biomedical Engineering (SBME) has recently been featured in the Research2Reality video above and an accompanying article. Titled “Solving Problems With a Little Bit of Everything”, SMBE is commended for its focus on collaboration across disciplines, encouraging those with diverse perspectives to work together and problem-solve.
INOVAIT is currently accepting applications for projects which are collaborative and commercialization-focused. The $125,000 Pilot Fund is meant to support the research and development of image-guided therapy technologies which integrate the use of artificial intelligence.
Proposal Deadline: December 20th 2022, 11:59pm PST
If you are interested in becoming certified by the Society of Clinical Research Associates (SoCRA) or the Association of Clinical Research Professionals (ACRP), the Clinical Research Professional (CRP) Certification Program though Clinical Trials BC is a fantastic opportunity.
For up to 20 professionals, Clinical Trials BC will be providing preparation resources for the certification exam such as exam preparation sessions, as well as a $400 partial reimbursement towards examination fees for CCRC or CCRP examinations. The program is designed for BC clinical research professionals based at health authority-affiliated sites as well as academic sites.
Dr. Ali Bashashati at the Vancouver Coastal Health Research Institute uses novel technique to address diagnosis of the deadliest female reproductive cancer, ovarian cancer. In his research, Dr. Bashashati had pathologists with expertise in gynaecological cancers classify ovarian cancer in 948 tissue specimens. When these expert classifications were compared against an AI algorithm’s, the computer model was very accurate. This study shows promising results in the potential that AI may have in providing diagnoses in an optimal time window to ultimately enhance patient outcomes.
We congratulate Dr. Thomas Madden on his recent BIOTECanada’s 2022 Gold Leaf award.
Dr. Thomas was awarded in the category of Game Changing Industry Leadership. He is the President & CEO of Acuitas Therapeutics, which has significantly contributed towards the development of the Pfizer/BioNTech COVID-19 vaccine.
We are delighted to announce the appointment of Dr. Dean Regier as Associate Director for the Academy of Translational Medicine (ATM).
Dr. Regier is an associate professor at the School of Population and Public Health and a Senior Scientist at the BC Cancer Research Institute. He also serves on B.C.’s Drug Benefit Council, which makes evidence-informed recommendations to the Ministry of Health about which drugs to cover under the provincial PharmaCare program.
As the previous Co-Director pro tem of the ATM, and the current Chair of the ATM Regulatory Advisory Council, Dr. Regier has comprehensive knowledge of the ATM organization and ongoing initiatives. As Associate Director of the ATM, Dr. Regier will assist and support the Director with strategic direction and decision-making related to the ATM.
Dr. Regier says: “I’m delighted to be named Associate Director of the ATM. The ambitious goal of the ATM is to halve the time it takes for new, effective health products to reach patients. To achieve this, we are seeking to establish the ATM as a world-leading centre of excellence. Over the past year, we have worked to realize our goals through engaging with and building a multi-disciplinary community, and through creating micro-certificate training programs in regulatory science and entrepreneurship.” Dr Regier goes on to say “My next steps with the ATM include working to build infrastructure at UBC and in BC’s health care system to further the generation of evidence for patient and public health”.
Please join us in congratulating Dr. Regier on his appointment.
If you are interested in becoming certified by the Society of Clinical Research Associates (SoCRA) or the Association of Clinical Research Professionals (ACRP), the Clinical Research Professional (CRP) Certification Program though Clinical Trials BC is a fantastic opportunity.
Dr. Ali Bashashati at the Vancouver Coastal Health Research Institute uses novel technique to address diagnosis of the deadliest female reproductive cancer, ovarian cancer. In his research, Dr. Bashashati had pathologists with expertise in gynaecological cancers classify ovarian cancer in 948 tissue specimens. When these expert classifications were compared against an AI algorithm’s, the computer model was very accurate. This study shows promising results in the potential that AI may have in providing diagnoses in an optimal time window to ultimately enhance patient outcomes.
